Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

Exelixis clinical trials

The registry lists 57 studies whose lead sponsor is Exelixis. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the Exelixis studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 18
Terminated: 14
Active, not recruiting: 10
Recruiting: 9
Not yet recruiting: 2
Approved for marketing: 1

Phase

Phase 1: 33
Phase 3: 15
Phase 2: 10
Phase 4: 1

Where

United States: 53
United Kingdom: 19
Spain: 17
France: 17
Australia: 17
Belgium: 16

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Exelixis.

Exelixis
Same company
Something wrong?
What is wrong with this name?A different company with a similar name, not ExelixisExelixis is owned by another companySomething else
What is right?A source, if you have one
No account needed. Please leave out personal details.
57 studies

Focus areas

Conditions Exelixis leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Neoplasms11

Studies

Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 →